WDFY3 and central nervous system cancer: Other studies suggested that the potential value of long noncoding RNA WDFY3-AS2 might be novel prognostic biomarker for lung adenocarcinoma (LUAD) [45], glioma [46], and esophageal cancer (EC) [47].